Pediatric Vaccines Market Value Share, Analysis and Segments 2016-2026

Vaccination is a technique by which person is made immune or resistant to an infectious disease. Vaccination has saved millions of lives including adults, children, and animals, providing them a better quality and healthier life from various microorganism such as virus and bacteria. This is one of the most important reason behind the growth of this market. Vaccines stimulate the body's own immune system to protect the person against subsequent infection or disease. Vaccines are generally segmented into two target markets, adult and pediatric. Pediatric vaccines are commonly used for the immunization of children and adolescents against various various infectious diseases, like diphtheria, influenza, hepatitis, pneumococcal diseases, and meningococcal diseases.

Pediatric Vaccines Market: Drivers and Restrains

Major growth drivers for the growth of global pediatric vaccines market are increasing private-public partnerships for the research and development activities, technological advancement in recombinant DNA technology, increasing healthcare expenditure. Both government and non-government bodies are focusing a lot on immunization campaigns to increase awareness about vaccination among population. However, rising costs of vaccines, low accessibility to remote areas and stringent regulation for approval of vaccines are some of the factors affecting the global pediatric vaccine.

Pediatric Vaccines Market: Segmentation

The global pediatric vaccines market can be segmented based on products, technology and types of diseases.

Based on vaccines type, global pediatric vaccine market can be segmented into following:

Live, attenuated vaccines,

Inactivated/killed vaccines,

Toxoid vaccines

Subunit/Conjugate

Recombinant vector vaccines

Based on diseases type, global pediatric vaccine can be segmented into following:

Diphtheria

Hepatitis A

Hepatitis B

Influenza

Measles

Meningococcal

Mumps

Haemophilus Influenzae type b (Hib)

Pertussis...